[1] Eccles C,Brock KK,Bissonnette JP,et al. Reproducibility of liver position using active breathing coordinator for liver cancer radiotherapy[J]. Int J Radiat Oncol Biol Phys,2006,64:751-759. [2] Wang L,Hayes S,Paskalev K,et al. Dosimetric comparison of stereotactic body radiotherapy using 4D CT and multiphase CT images for treatment planning of lung cancer: evaluation of the impact on daily dose coverage[J]. Radiother Oncol,2009,91:314-324. [3] Rosu M,Dawson LA,Balter JM,et al. Alterations in normal liver doses due to organ motion[J]. Int J Radiat Oncol Biol Phys,2003,57:1472-1479. [4] Herfarth KK,Debus J,Lohr F,et al. Extracranial stereotactic radiation therapy: set-up accuracy of patients treated for liver metastases[J]. Int J Radiat Oncol Biol Phys,2000,46:329-335. [5] Eccles CL,Patel R,Simeonov AK,et al. Comparison of liver tumor motion with and without abdominal compression using cine-magnetic resonance imaging[J]. Int J Radiat Oncol Biol Phys,2011,79:602-608. [6] Heinzerling JH,Papiez L,Chien S,et al. Stereotactic body radiation therapy: evaluation of setup accuracy and targetingmethods for a new couch integrated immobilization system[J]. Technol Cancer Res Treat,2008,7:197-206. [7] Paumier A,Ghalibafian M,Gilmore J,et al. Dosimetric benefits of intensity-modulated radiotherapy combined with the deep-inspiration breath-hold technique in patients with mediastinal Hodgkin′s lymphoma[J]. Int J Radiat Oncol Biol Phys,2012,82:1522-1527. [8] Dawson LA,Brock KK,Kazanjian S,et al. The reproducibility of organ position using active breathing control(ABC) during liver radiotherapy[J]. Int J Radiat Oncol Biol Phys,2001,51:1410-1421. [9] Zhong R,Wang J,Jiang X,et al. Hypofraction radiotherapy of liver tumor using cone beam computed tomography guidance combined with active breath control by long breath-holding[J]. Radiother Oncol,2012,3:379-385. [10] Korreman S,Persson G,Nygaard D,et al. Respiration-correlated image guidance is the most important radiotherapy motion management strategy for most lung cancer patients[J]. Int J Radiat Oncol Biol Phys,2012,83:1338-1343. [11] Schreibmann E,Chen GT,Xing L. Image interpolation in 4D CT using a BSpline deformable registration model[J]. Int J Radiat Oncol Biol Phys,2006,64:1537-1550. [12] Velec M,Moseley JL,Eccles CL,et al. Effect of breathing motion on radiotherapy dose accumulation in the abdomen using deformable registration[J]. Int J Radiat Oncol Biol Phys,2011,80:265-272. [13] Yue J,Sun X,Cai J,et al. Lipiodol: a potential direct surrogate for cone-beam computed tomography image guidance in radiotherapy of liver tumor[J]. Int J Radiat Oncol Biol Phys,2012,82:834-841. [14] 任志刚,胡伟刚,陈颢,等.CT与 MRI图像融合技术确定原发性肝癌三维适形放疗靶区应用研究[J].中华放射肿瘤学杂志,2009,18:11-14. [15] 任志刚,胡伟刚,陈颢,等.CT/MRI图像融合精度对原发性肝癌三维适形放疗的剂量学影响[J].肿瘤,2009,29:265-268. [16] Merle P,Mornex F,Trepo C. Innovative therapy for hepatocellular carcinoma: three-dimensional high-dose photon radiotherapy. Cancer Lett,2009,286:129-133. [17] Ren ZG,Zhao JD,Gu K,et al. Three-dimensional conformal radiation therapy and intensity-modulated radiation therapy combined with transcatheter arterial chemoembolization for locally advanced hepatocellular carcinoma: an irradiation dose escalation study[J]. Int J Radiat Oncol Biol Phys,2011,79:496-502. [18] Fuss M,Salter BJ,Herman TS,et al. External beam radiation therapy for hepatocellular carcinoma: potential of intensity-modulated and image-guided radiation therapy[J]. Gastroenterology,2004,127(5 Supll 1):S206-S217. [19] Yin Y,Ma C,Gao M,et al. Dosimetric comparison of RapidArc with fixed gantry intensity-modulated radiotherapy treatment for multiple liver metastases radiotherapy[J]. Med Dosim,2011,36:448-454. [20] Dawson LA,Eccles C,Craig T. Individualized image guided iso-NTCP based liver cancer SBRT[J]. Acta Oncol,2006,45:856-864. [21] Feng M,Ben-Josef E. Radiation therapy for hepatocellular carcinoma[J]. Semin Radiat Oncol,2011,21:271-277. [22] Mornex F,Girard N,Beziat C,et al. Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curativetherapies-mature results of the French phase Ⅱ RTF-1 trial[J]. Int J Radiat Oncol Biol Phys,2006,66:1152-1158. [23] Ben-Josef E,Normolle D,Ensminger WD,et al. Phase Ⅱ trial of high dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies[J]. J Clin Oncol,2005,23:8739-8747. [24] Aoki K1,Okazaki N,Okada S,et al.Radiotherapy for hepatocellular carcinoma: clinicopathological study of sevenautopsy cases[J].Hepatogastroenterology,1994,41:427-431. [25] Park HC,Seong J,Han KH,et al. Dose-response relationship in local radiotherapy for hepatocellular carcinoma[J]. Int J Radiat Oncol Biol Phys,2002,54:150-155. [26] Bucci M,Kara B,Aa RM. Advances in radiation therapy: conventional to 3D,to IMRT,to 4D,and beyond[J]. CA Cancer J Clin,2005,55:117-134. [27] Lee MT,Purdie TG,Eccles CL,et al. Comparison of simple and complex liver intensity modulated radiotherapy[J]. Radiat Oncol,2010,5:115-124. [28] Cheng JC,Wu JK,Huang CM,et al. Dosimetric analysis and comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy for patients with hepatocellular carcinoma and radiation-induced liver disease[J]. Int J Radiat Oncol Biol Phys,2003,56:229-234. [29] Lee IJ,Seong J,Koom WS,et al. Selection of the optimal radiotherapy technique for locally advanced hepatocellular carcinoma[J]. Jpn J Clin Oncol,2011,41:882-889. [30] Hall EJ. Intensity-modulated radiation therapy,protons,and the risk of second cancers[J].Int J Radiat Oncol Biol Phys,2006,65:1-7. [31] Taddei PJ,Howell RM,Krishnan S,et al. Risk of second malignant neoplasm following proton versus intensity-modulated photon radiotherapies for hepatocellular carcinoma[J]. Phys Med Biol,2010,55:7055-7065. [32] Yin Y,Ma C,Gao M,et al. Dosimetric comparison of RapidArc with fixed gantry intensity-modulated radiotherapy treatment for multiple liver metastases radiotherapy[J]. Med Dosim,2011,36:448-454. [33] Tsai YC,Tsai CL,Hsu FM,et al. Superior liver sparing by combined coplanar/noncoplanar volumetric-modulated arc therapy for hepatocellular carcinoma: a planning and feasibility study[J]. Med Dosim,2013,13:56-63. [34] Kuo YC,Chiu YM,Shih WP,et al. Volumetric intensity-modulated Arc(RapidArc) therapy for primary hepatocellular carcinoma: comparison with intensity-modulated radiotherapy and 3-D conformal radiotherapy[J]. Radiat Oncol,2011,6:76-85. [35] Xi M,Zhang L,Li QQ,et al. Assessing the role of volumetric-modulated arc therapy in hepatocellular carcinoma[J]. J Appl Clin Med Phys,2013,3:41-62. [36] Xi M,Zhang L,Zhao L,et al. Effectiveness of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombosis[J/OL]. PLoS One,2013,5:e63864[2013-11-10]. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667854/. [37] Price TR,Perkins SM,Sandrasegaran K,et al. Evaluation of response after stereotactic body radiotherapy for hepatocellular carcinoma[J]. Cancer,2012,12:3191-3198. [38] Louis C,Dewas S,Mirabel X,et al. Stereotactic radiotherapy of hepatocellular carcinoma: preliminary results[J]. Technol Cancer Res Treat,2010,9:479-487. [39] Tsang DS,Voncken FE,Tse RV,et al. A Randomized Controlled Trial of Lorazepam to reduce liver motion in patients receiving upper abdominal radiation therapy[J]. Int J Radiat Oncol Biol Phys,2013,5:881-887. [40] Park JC,Park SH,Kim JH,et al. Liver motion during cone beam computed tomography guided stereotactic body radiation therapy[J]. Med Phys,2012,10:6431-6442.
2014, Vol. 23 
